Drug Profile
Peanut allergy immunotherapy - Laboratorios Leti
Alternative Names: Peanut native extract - Laboratorios LetiLatest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Laboratorios LETI
- Class Allergens; Antiallergics; Food allergy immunotherapies; Immunotherapies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Peanut hypersensitivity
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for research development in Peanut-hypersensitivity in Spain (SC)
- 03 Mar 2017 Early research in Peanut hypersensitivity in Spain (SC)
- 03 Mar 2017 Pharmacodynamics and immunogenicity data from preclinical studies in Peanut hypersensitivity presented at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAI-2017) (3233976; 3234092)